Eyevensys, a French ophthalmic therapy company, has hired Violaine Desort-Hénin as Clinical Director.
In this position, Desort-Hénin will be responsible for overseeing the development of the Eyevensys clinical development programme.
Desort-Hénin combines several competencies, from vet medicine and surgery to toxicology and clinical trial management, particularly in the area of ophthalmology. Various professional experiences have enabled her to acquire a translational medical expertise and a deep understanding of the complex physiopathology underlying ocular diseases. She was previously Head of Preclinical and Clinical Development in a listed biotech company for more than five years. During her previous tenure, she participated in all phases of development up to clinical Phase III and in the design of strategic international programmes.